Clinical Trial Update: Gain-framed Messages and NRT for Lung Cancer Screening Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated gain-framed messages plus nicotine replacement therapy to promote smoking cessation among individuals undergoing lung cancer screening…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Tobacco Use Disorder

Drugs mentioned

• Nicotine replacement therapy (nicotine replacement therapy)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Lung Cancer Screening, Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2024-11-14